The firm says it has: "a vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-time curative treatment." Freeline is headquartered in the UK and has operations in Germany and the USA.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze